In silico and invitro Antidiabetic Characterization and ADME Studies of Rhus parviflora

Abstract

The study was planned to trace out connection among receptors responsible for the development of diabetes mellitus and active constituents of Rhus parviflora by in silico and in vitro methods. A molecular docking study was carried out for selected compounds after screening of all chemical constituents present in plant. Initial screening was carried through Lipinski’s rule of five along with ADME study of the reported phytoconstituents. For estimation of Antidiabetic potential of all selected constituent total 6 PDB namely 1IR3 (Insulin receptor), 1US0 (Aldose Reductase), 2FV6 (Protein tyrosine phosphatase 1), 2OQV (Human Dipeptidyl Peptidase IV) 2QV4 (α-amylase), 5NN6 (α- glucosidase) were selected. Molegro Virtual Docker tool was employed for the Molecular Docking studies. 4’-O-beta-D-Glucosyl-cis-p-coumaric acid, Kaempferol, Myrecetin, Quercetin, Taxifolin, and Isorhamnetin exhibited efficient hydrogen bonding as well as mol dock score with all selected 6 receptor PDB in contrast to standard drug Glibenclamide. In vitro study results of RPME exhibited 60.58±0.6, 54.64±2.46 percent inhibition in α- Glucosidase Inhibition Assay and α- Amylase Inhibition Assay, in contrast standard acarbose exhibited 71.35±1.84 and 67.76±1.97 percent inhibition respectively. The entire study gives understanding that chosen plant presumably has antidiabetic potential because of considered biomarkers.